Fig. 4

DPP-IV in blood mononuclear cell (BMNC) in RA patients with clinical improvement of the disease. Cell surface DPP-IV-like enzymatic activity (n = 18) and the median fluorescence intensity (MFI) of DPP-IV in lymphocytes (n = 14) were determined in patients exhibiting at least a moderate improvement of the disease, individual entry and follow-up values are depicted. *p < 0.05, Wilcoxon pair test